Goldman Sachs Group Inc Terns Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 415,021 shares of TERN stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
415,021
Previous 415,021 -0.0%
Holding current value
$1.62 Million
Previous $1.15 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$2.76 - $5.79 $198,639 - $416,712
71,971 Added 20.98%
415,021 $1.15 Million
Q4 2024

Feb 11, 2025
SELL
$5.53 - $8.36 $419,268 - $633,830
-75,817 Reduced 18.1%
343,050 $1.91 Million
Q3 2024

Nov 14, 2024
SELL
$6.49 - $10.8 $1.82 Million - $3.02 Million
-279,847 Reduced 40.05%
418,867 $3.49 Million
Q2 2024

Aug 13, 2024
BUY
$4.54 - $8.2 $2.23 Million - $4.03 Million
491,728 Added 237.57%
698,714 $4.76 Million
Q1 2024

May 15, 2024
BUY
$4.86 - $8.19 $589,979 - $994,225
121,395 Added 141.83%
206,986 $1.36 Million
Q4 2023

Feb 13, 2024
SELL
$3.37 - $6.86 $585,385 - $1.19 Million
-173,705 Reduced 66.99%
85,591 $555,000
Q3 2023

May 14, 2024
BUY
$4.7 - $8.55 $816,413 - $1.49 Million
173,705 Added 202.95%
259,296 $1.3 Million
Q3 2023

Nov 14, 2023
BUY
$4.7 - $8.55 $947,115 - $1.72 Million
201,514 Added 348.75%
259,296 $1.3 Million
Q2 2023

May 14, 2024
SELL
$7.35 - $13.29 $231,686 - $418,927
-31,522 Reduced 35.3%
57,782 $505,000
Q2 2023

Aug 14, 2023
SELL
$7.35 - $13.29 $231,686 - $418,927
-31,522 Reduced 35.3%
57,782 $505,000
Q1 2023

May 14, 2024
BUY
$7.91 - $12.0 $620,729 - $941,688
78,474 Added 724.6%
89,304 $1.06 Million
Q1 2023

May 11, 2023
BUY
$7.91 - $12.0 $620,729 - $941,688
78,474 Added 724.6%
89,304 $1.06 Million
Q4 2022

May 14, 2024
SELL
$4.62 - $10.18 $5,017 - $11,055
-1,086 Reduced 9.11%
10,830 $110,000
Q4 2022

Feb 13, 2023
SELL
$4.62 - $10.18 $5,017 - $11,055
-1,086 Reduced 9.11%
10,830 $110,000
Q3 2022

May 14, 2024
SELL
$1.87 - $6.42 $8,736 - $29,994
-4,672 Reduced 28.16%
11,916 $70,000
Q3 2022

Nov 10, 2022
SELL
$1.87 - $6.42 $8,736 - $29,994
-4,672 Reduced 28.16%
11,916 $0
Q2 2022

May 14, 2024
SELL
$1.5 - $3.0 $103,504 - $207,009
-69,003 Reduced 80.62%
16,588 $41,000
Q2 2022

Aug 15, 2022
BUY
$1.5 - $3.0 $241 - $483
161 Added 0.98%
16,588 $41,000
Q1 2022

May 16, 2022
BUY
$2.83 - $6.7 $3,449 - $8,167
1,219 Added 8.02%
16,427 $49,000
Q4 2021

Feb 14, 2022
BUY
$5.65 - $10.73 $85,925 - $163,181
15,208 New
15,208 $108,000

Others Institutions Holding TERN

# of Institutions
143
Shares Held
84.5M
Call Options Held
256K
Put Options Held
133K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $147M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email